European & Developing Countries Clinical Trials Partnership (ECDTP) is partnering with the AIHD on a project dubbed Adoption of Levo-Praziquantel 150mg for Schistosomiasis by endemic countries. (ADOPT) (2021-2025) with the aim of having an evaluation of operational aspects and practices of orally administered drugs. The main objective of the project is to gain a better understanding of the operational factor and practices influencing pediatric drug dosing and oral administration of Praziquantel for treatment of Schistosomiasis in Kenya. AIHD oversees the Social Science & mobilization aspects of the project.